A UK study estimates that children who receive the human papillomavirus (HPV) vaccine at around 12–13 have a close to zero risk of dying from cervical cancer before the age of 30. Both outlets report that the findings are based on modelling that projects how vaccination timing and coverage could affect long-term cancer outcomes. The study’s conclusion is focused specifically on deaths occurring before age 30, rather than overall cervical cancer risk across a lifetime. The reporting also notes that the protective effect is linked to administering the vaccine during early adolescence, before many people would have exposure to HPV. While the study suggests very low mortality risk in the pre-30 age group, the articles describe it as an estimate from a study rather than direct observation of decades-long outcomes. Overall, the coverage aligns on the same core message: vaccinating at ages 12–13 is associated with an extremely low estimated risk of dying from cervical cancer before age 30.
Study estimates HPV vaccine at 12–13 leads to near-zero cervical cancer death risk before age 30
A UK study estimates that children who receive the human papillomavirus (HPV) vaccine at around 12–13 have a close to zero risk of dying from cervical cancer before the age of 30. Both outlets report...
- A UK study estimates an extremely low—close to zero—risk of dying from cervical cancer before age 30 for people vaccinated with HPV at age 12–13.
- The estimate is based on vaccination given during early adolescence (around ages 12 to 13).
- Both reports describe the result as a projected/estimated risk rather than a direct long-term death count.
- The findings focus on mortality before age 30, not lifetime risk.
Children who receive the HPV vaccine at age 12 to 13 have close to zero risk of dying from cervical cancer before the age of 30, a UK study has found.
2 months agoChildren who are vaccinated for HPV at age 12-13 have close to zero risk of dying from cervical cancer before they are 30, a study estimates.
2 months ago
Ugandan Tooro King Oyo Nyimba, once the world’s youngest monarch, dies at 34
Ugandan traditional ruler Oyo Nyimba, king of the Tooro kingdom, dies at 34. Multiple outlets report that his death foll...
Procam launches “HDOR: 100 Days of Running” to build long-term running habits
Procam launches “HDOR – 100 Days of Running,” a new initiative designed around 100 days of running and movement. The pro...
Reporter Stephen Wright revisits investigation into Albanian cocaine trafficking links to Britain
Reporter Stephen Wright revisits an investigation he conducted in Guayaquil, Ecuador, in late 2022, looking at links bet...